Showing 1 - 20 results of 34 for search 'Jonas S. Heitmann', query time: 0.06s
Refine Results
-
1
-
2
-
3
Protocol of a first-in-human clinical trial to evaluate the safety, tolerability, and preliminary efficacy of the bispecific CD276xCD3 antibody CC-3 in patients with colorectal can... by Susanne Jung, Susanne Jung, Susanne Jung, Richard F. Schlenk, Richard F. Schlenk, Christopher Hackenbruch, Christopher Hackenbruch, Christopher Hackenbruch, Sandra S.L. Roldan Pinzon, Michael Bitzer, Martin Pflügler, Juliane S. Walz, Juliane S. Walz, Juliane S. Walz, Gundram Jung, Jonas S. Heitmann, Jonas S. Heitmann, Jonas S. Heitmann, Helmut R. Salih, Helmut R. Salih
Published 2024-02-01
Article -
4
-
5
-
6
Genetic Loss of LCK Kinase Leads to Acceleration of Chronic Lymphocytic Leukemia by Melanie Märklin, Melanie Märklin, Alexander R. Fuchs, Claudia Tandler, Jonas S. Heitmann, Jonas S. Heitmann, Helmut R. Salih, Joseph Kauer, Leticia Quintanilla-Martinez, Stefan Wirths, Hans-Georg Kopp, Hans-Georg Kopp, Martin R. Müller, Martin R. Müller
Published 2020-09-01
Article -
7
Prevalence of COVID-19-associated symptoms during acute infection in relation to SARS-CoV-2-directed humoral and cellular immune responses in a mild-diseased convalescent cohort by Christian M. Tegeler, Tatjana Bilich, Yacine Maringer, Helmut R. Salih, Juliane S. Walz, Annika Nelde, Jonas S. Heitmann
Published 2022-07-01
Article -
8
Protocol of a prospective, multicentre phase I study to evaluate the safety, tolerability and preliminary efficacy of the bispecific PSMAxCD3 antibody CC-1 in patients with castrat... by Gundram Jung, Jonas S Heitmann, Juliane S Walz, Martin Pflügler, Joseph Kauer, Richard F Schlenk, Helmut R Salih
Published 2020-10-01
Article -
9
-
10
-
11
iVAC-XS15-CLL01: personalized multi-peptide vaccination in combination with the TLR1/2 ligand XS15 in CLL patients undergoing BTK-inhibitor-based regimens by Alexander Englisch, Alexander Englisch, Alexander Englisch, Clara Hayn, Clara Hayn, Susanne Jung, Susanne Jung, Susanne Jung, Jonas S. Heitmann, Jonas S. Heitmann, Jonas S. Heitmann, Christopher Hackenbruch, Christopher Hackenbruch, Christopher Hackenbruch, Yacine Maringer, Yacine Maringer, Annika Nelde, Annika Nelde, Marcel Wacker, Marcel Wacker, Monika Denk, Lisa Zieschang, Christine Kammer, Peter Martus, Helmut R. Salih, Helmut R. Salih, Juliane S. Walz, Juliane S. Walz, Juliane S. Walz
Published 2024-08-01
Article -
12
-
13
IgG-based B7-H3xCD3 bispecific antibody for treatment of pancreatic, hepatic and gastric cancer by Martina S. Lutz, Martina S. Lutz, Latifa Zekri, Latifa Zekri, Latifa Zekri, Laura Weßling, Laura Weßling, Susanne Berchtold, Susanne Berchtold, Susanne Berchtold, Jonas S. Heitmann, Jonas S. Heitmann, Ulrich M. Lauer, Ulrich M. Lauer, Ulrich M. Lauer, Gundram Jung, Gundram Jung, Helmut R. Salih, Helmut R. Salih
Published 2023-04-01
Article -
14
-
15
-
16
AML-VAC-XS15-01: protocol of a first-in-human clinical trial to evaluate the safety, tolerability and preliminary efficacy of a multi-peptide vaccine based on leukemia stem cell an... by Susanne Jung, Susanne Jung, Susanne Jung, Annika Nelde, Annika Nelde, Yacine Maringer, Yacine Maringer, Monika Denk, Monika Denk, Monika Denk, Lisa Zieschang, Lisa Zieschang, Lisa Zieschang, Christine Kammer, Christine Kammer, Melek Özbek, Melek Özbek, Melek Özbek, Peter Martus, Christopher Hackenbruch, Christopher Hackenbruch, Christopher Hackenbruch, Alexander Englisch, Alexander Englisch, Alexander Englisch, Jonas S. Heitmann, Jonas S. Heitmann, Jonas S. Heitmann, Helmut R. Salih, Helmut R. Salih, Juliane S. Walz, Juliane S. Walz, Juliane S. Walz, Juliane S. Walz
Published 2024-10-01
Article -
17
-
18
Platelet-Expressed TNFRSF13B (TACI) Predicts Breast Cancer Progression by Clemens Hinterleitner, Clemens Hinterleitner, Yanjun Zhou, Yanjun Zhou, Claudia Tandler, Claudia Tandler, Jonas S. Heitmann, Jonas S. Heitmann, Korbinian N. Kropp, Martina Hinterleitner, Martina Hinterleitner, André Koch, Andreas D. Hartkopf, Lars Zender, Lars Zender, Lars Zender, Helmut R. Salih, Helmut R. Salih, Stefanie Maurer, Stefanie Maurer, Stefanie Maurer
Published 2021-03-01
Article -
19
Tocilizumab, but not dexamethasone, prevents CRS without affecting antitumor activity of bispecific antibodies by Hans-Georg Rammensee, Melanie Märklin, Gundram Jung, Jonas S Heitmann, Joseph Kauer, Helmut R Salih, Latifa Zekri, Lukas Osburg, Sebastian Hörner, Stefanie Müller
Published 2020-05-01
Article -
20
Induction of NK cell reactivity against acute myeloid leukemia by Fc-optimized CD276 (B7-H3) antibody by Sylwia A. Stefańczyk, Ilona Hagelstein, Martina S. Lutz, Stefanie Müller, Samuel J. Holzmayer, Grace Jarjour, Latifa Zekri, Jonas S. Heitmann, Helmut R. Salih, Melanie Märklin
Published 2024-04-01
Article